Hajiabdolbaghi Mahboubeh, Rasoulinejad Maryam, Abdollahi Alireza, Paydary Koosha, Valiollahi Pegah, SeyedAlinaghi SeyedAhmad, Parsa Maziar, Jafari Sirous
Iranian Research Center for HIV/AIDS (IRCHA), Tehran University of Medical Sciences, Iran.
Acta Med Iran. 2011;49(12):801-5.
The purpose of this study was to assess the possible correlation between Brucella and HIV infections. Iran is a country where HIV infection is expanding and Brucellosis is prevalent. In the present study, 184 HIV infected patients were assigned and for all of them HIV infection was confirmed by western blot test. In order to identify the prevalence rate of Brucella infection and systemic brucellosis in these subjects, sera samples were obtained and Brucella specific serological tests were performed to reveal antibody titers. Detailed history was taken and physical examination was carried out for all of patients. 11 (6%) subjects had high titers but only 3 of them were symptomatic. Most of these subjects were injection drug user (IDU) men and one was a rural woman. Considering both prevalence rates of Brucella infection (3%) and symptomatic brucellosis (0.1%) in Iran, our HIV positive patients show higher rates of Brucella infection and systemic brucellosis. Preserved cellular immunity of participants and retention of granulocytes activity may explain this poor association; whereas other explanations such as immunological state difference and non-overlapping geographical distribution of the 2 pathogens have been mentioned by various authors.
本研究的目的是评估布鲁氏菌感染与艾滋病毒感染之间可能存在的相关性。伊朗是一个艾滋病毒感染呈扩大趋势且布鲁氏菌病流行的国家。在本研究中,选取了184名艾滋病毒感染患者,所有患者的艾滋病毒感染均通过蛋白质印迹法检测得以确认。为了确定这些受试者中布鲁氏菌感染和系统性布鲁氏菌病的患病率,采集了血清样本并进行了布鲁氏菌特异性血清学检测以揭示抗体滴度。对所有患者进行了详细的病史采集和体格检查。11名(6%)受试者抗体滴度较高,但其中只有3人有症状。这些受试者大多数是注射吸毒者(IDU)男性,1名是农村女性。考虑到伊朗布鲁氏菌感染率(3%)和症状性布鲁氏菌病患病率(0.1%),我们的艾滋病毒阳性患者显示出更高的布鲁氏菌感染率和系统性布鲁氏菌病患病率。参与者保留的细胞免疫和粒细胞活性可能解释了这种较弱的相关性;而其他解释,如免疫状态差异和这两种病原体不重叠的地理分布,也被不同作者提及。